Sidley has advised Sensei Biotherapeutic on the transaction. Cooley has advised Faeth Therapeutics. Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a Nasdaq-listed clinical-stage biotechnology company, has acquired Faeth...
Sensei Biotherapeutics Acquires Faeth Therapeutics
Faeth Therapeutics’ $47 Million Series A Financing
Wilson Sonsini advised Faeth Therapeutics on the deal. Faeth Therapeutics, a cancer metabolism company, announced the completion of a Series A financing of $47 million led...